期刊文献+

沉默Rheb对DDP耐药非小细胞肺癌细胞活力和凋亡的影响及机制研究

Effect and mechanism of si-Rheb on viability and apoptosis of DDP-resistant nun-small cell lung cancer cells
下载PDF
导出
摘要 目的:研究沉默Rheb对DDP耐药非小细胞肺癌(NSCLC)细胞活力和凋亡的影响,并探索其作用机制。方法:体外培养非小细胞肺腺癌细胞A549和顺铂耐药的A549细胞(A549/DDP)。转染Rheb-siRNA(si-Rheb)至A549和A549/DDP细胞。采用CCK-8法、Annexin-V/PI双染,qPCR和Western blotting方法检测si-Rheb对细胞活力和凋亡的影响。结果:Rheb在A549/DDP细胞中高表达(P<0.05)。转染si-Rheb可有效抑制A549和A549/DDP细胞中Rheb的表达,显著降低A549和A549/DDP细胞活力,诱导细胞凋亡,促进A549/DDP对DDP的敏感性(P<0.05)。此外,转染si-Rheb显著影响了凋亡相关蛋白,如细胞色素C、RARP和Caspase-3表达,并抑制了mTOR-S6信号通路的过度激活(P<0.05)。结论:Rheb通过mTOR-S6信号通路调控DDP耐药A549细胞对DDP的敏感性。 Objective:To explore the effects of Rheb knockdown on viability and apoptosis of DDP-resistant non-small cell lung cancer(NSCLC)cells and its possible mechanisms.Methods:Non-small cell lung adenocarcinoma cell A549 and DDP-resistant A549(A549/DDP)cells were cultured in vitro.Transfected Rheb-siRNA(si-Rheb)into A549 and A549/DDP cells.CCK-8 assay,Annexin-V/PI double stain kit,qPCR and Western blotting were used to investigate the effects of Rheb siRNA(si-Rheb)on viability and apoptosis of cells.Results:Rheb was upregulated in A549/DDP cells(P<0.05).Transfection with si-Rheb into A549 and A549/DDP cells significantly inhibited expression of Rheb,significantly suppressed cell viability,induced cell apoptosis,and promoted sensibility of A549/DDP to DDP(P<0.05).In addition,si-Rheb markedly effected expressions of apoptosis related proteins,such as Cytochrome-C,RARP and Caspase-3,and suppressed overactivated of mTOR-S6 signal pathway(P<0.05).Conclusion:Rheb promoted the sensitivity of A549/DDP cells to DDP may through regulating the mTOR-S6 signal pathway.
作者 段进进 尚立群 王莉 吴桦 苗毅 董玉 DUAN Jinjin;SHANG Liqun;WANG Li;WU Hua;MIAO Yi;DONG Yu(Department of Respiratory Medicine,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2023年第8期1683-1686,共4页 Chinese Journal of Immunology
基金 陕西省重点研发项目(2018SF-062)。
关键词 RHEB 非小细胞肺癌 耐药性 mTOR-S6信号通路 凋亡 Rheb Non-small cell lung cancer Drug resistance mTOR-S6 signal pathway Apoptosis
  • 相关文献

参考文献3

二级参考文献17

  • 1王岩,徐建明,宋三泰.表皮生长因子受体靶向药物作用机制与相关标志物的研究现状[J].中华肿瘤杂志,2005,27(9):573-576. 被引量:33
  • 2杨鹭,刘叙仪,方健,安彤同,吴梅娜.吉非替尼治疗91例晚期非小细胞肺癌疗效分析[J].中华肿瘤杂志,2006,28(6):474-477. 被引量:36
  • 3Baselga J. New therapeutic agents targeting the epidermal growth factor receptor. J Clin Oncol,2000, 18 ( Suppl 21 ) : 54s - 59s.
  • 4Sako Y, Minoghchi S,Yangida T. Single- molecule imaging of EGFR signaling on the surface of living cell. Nat Cell Biol,2002,2 : 168 - 172.
  • 5Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic Subtype and smoking history predict sensityvity to gefitinib in advanced non - small - cell lung cancer. J Clin Oncol,2004,22 : 1103 - 1109.
  • 6Mitsudomi T, Kosaka, T Endoh H, et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after Gefitinib treatment in patients with non - small - cell lung cancer with postoperative recurrence. J Clin Oncol , 2005,23 : 2513 - 2520.
  • 7Tokumo M, Toyooka S, Kiurs K, et al. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non - small cell lung cancers. Clin Cancer Res ,2005,11 : 1167 - 1173.
  • 8Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer:Correlation with clinical response to gefitinib therapy. Science,2004,304 : 1497 - 1500.
  • 9Tamura K, Fukuoka M. Gefitinib in non - small cell lung cancer. Expert Opin Pharmacother, 2005,6:985 -993.
  • 10周道平,聂国庆.吉非替尼治疗晚期非小细胞肺癌临床观察[J].安徽医学,2008,29(2):163-164. 被引量:3

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部